Daily Report | FDA Approval of Pfizer Vaccine Weakens Many Plaintiff Claims, Greenlights Vax Deadlines, Lawyers Say

Brett Coburn is quoted on the expected increase in companies that will mandate vaccine requirements following the U.S. Food and Drug Administration’s full approval of the Pfizer-BioNTech coronavirus vaccine.

In the past week, the FDA authorized Pfizer’s and Merck’s oral antivirals for the treatment of COVID-19. The Biden-Harris Administration released the Trucking Action Plan. The CDC endorsed ACIP recommendation of preference for Pfizer-BioNTech and Moderna vaccine boosters. The new recommended Tris vaccine buffer leads to greater stability and requires no dilution. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.

In the past week, the FDA granted an EUA for the Pfizer-BioNTech vaccine for use in children 5–11 years of age. The agency also participated in the launch of the Bespoke Gene Therapy Consortium. The Administration held a global supply chain summit to strengthen cooperation and advocate for diversification of supply chains. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review.

In the past week, the FDA Vaccines and Related Biological Products Advisory Committee recommended authorization of the Pfizer-BioNTech vaccine for use in children 5–11 years of age. The CDC formally endorsed the booster dose for the Moderna and J&J vaccines. President Biden met with Dr. Robert Califf for the top FDA post. See details for these and other supply chain developments in the Medical Products Supply Chain Week in Review. 

After more than a year of various travel bans, the Biden Administration announced a uniform policy for air travel from certain countries and another for land crossings. Our Labor & Employment Group unpacks what those policies entail and which travelers are affected.